STAT

Opinion: Concussions, broken bones, and more: a week of football in the U.S.

In 1907, the Journal of the American Medical Association editorialized that football was "no game for boys to play." But they still are, and have the concussions, broken bones, and…
In some communities, tackle football starts early.

News about concussions and other injuries to young football players appears with alarming frequency, as do reports of the long-term damage to NFL players.

Young pro players are leaving the game for fear of permanent harm to their brains and bodies. Last month, Joshua Perry discussed his retirement at age 24 after suffering six concussions. He’s following in the footsteps of A.J. Tarpley, who retired at age 23, also because of concussion concerns.

In March, USA Today called for a ban on tackle football for kids under 14, and one month later the journal Pediatrics reported results from a survey in which a majority of parents who responded supported age restrictions on tackling.

Still, as our third annual Football Injury Highlight Reel attests, the and editions, this year’s emphasizes injuries among youths, because those under 18 represent the of football players in the United States. We include pro stats as a comparison and to indicate the persistence and prevalence of injuries.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks